Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0024530 (
malaria
)
44,886
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The theme of World Health Day 2018 is 'Universal health coverage: everyone, everywhere' under the slogan 'Health for All'. Universal Health Coverage (UHC), as pertains to blood and blood products, means that all individuals and communities have access to affordable and timely supplies of safe and quality-assured blood and blood products. Blood and blood products are essential components in the proper management of women suffering from bleeding associated with pregnancy and childbirth; children suffering from severe anaemia due to
malaria
and malnutrition; patients with blood and bone marrow disorders and
immune deficiency
conditions; victims of trauma, emergencies, disasters and accidents; and patients undergoing advanced medical and surgical procedures.
...
PMID:The role of access to affordable and quality assured blood and blood products for achieving Universal Health Coverage (Editorial). 3037 Sep 20
The
malaria
parasite's complex journey through the
Anopheles
mosquito vector provides multiple opportunities for targeting
Plasmodium
with recombinant effectors at different developmental stages and different host tissues. We have designed and expressed transgenes that efficiently suppress
Plasmodium
infection by targeting the parasite with multiple independent endogenous and exogenous effectors at multiple infection stages to potentiate suppression and minimize the probability for development of resistance to develop. We have also addressed the fitness impact of transgene expression on the mosquito. We show that highly potent suppression can be achieved by targeting both pre-oocyst stages by transgenically overexpressing either the endogenous
immune deficiency
immune pathway transcription factor Rel2 or a polycistronic mRNA encoding multiple antiparasitic effectors and simultaneously targeting the sporozoite stages with an anti-sporozoite single-chain antibody fused to the antiparasitic protein Scorpine. Expression of the selected endogenous effector systems appears to pose a lower fitness cost than does the use of foreign genes.
...
PMID:Versatile transgenic multistage effector-gene combinations for
Plasmodium falciparum
suppression in
Anopheles
. 3242 91
<< Previous
1
2
3